Based on the findings of several studies, the serum levels ratio of RANKL and OPG in the bone microenvironment is vital for osteoclasts formation and it also plays a role in the pathogenesis, prevention, and treatment of bone metabolism disorders [40]. The gene discussed is TNFSF11; the disease is metabolic bone disorder.